Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05007717
Other study ID # STUDY00011096
Secondary ID UH3HD096906
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 19, 2022
Est. completion date November 30, 2023

Study information

Verified date October 2023
Source University of Washington
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will conduct a Phase III cluster randomized controlled trial (cRCT) to evaluate the effectiveness of the implementation of a data-informed stepped care (DiSC) intervention for HIV treatment management among adolescents living with HIV (ALHIV) in high-volume HIV clinics in Kenya. The DiSC intervention is comprised of a system to assign ALHIV to care based on their health needs and the different levels of care for each assignment group. The primary outcome will be ALHIV retention, and the secondary outcomes will include adherence, viral non-suppression, and receipt of differentiated care among ALHIV.


Description:

UNAIDS '95-95-95' targets cannot be achieved without additional support for adolescents living with HIV (ALHIV) to increase retention in care and to support viral suppression. Risk prediction tools as well as a stepped care approach to care can support differentiation of ALHIV to different risk groups, and tailor care based on risk. The investigators have conducted informative work with ALHIV, caregivers, healthcare workers (HCW) and policy makers, and has developed a clinical prediction tool to identify ALHIV at highest risk of not being retained in care and poor viral suppression that could be adapted to identify adolescents who may need more support in their care. Understanding how best to use the risk prediction tool as well as how to tailor services based on risk may ultimately result in more efficient HIV care services, as well as adequate support for ALHIV at highest risk of poor outcomes. Building on that informative work, in this protocol, the investigators will conduct a Phase III cluster randomized controlled trial (cRCT) by implementing a data-informed stepped care (DiSC) intervention of ALHIV HIV treatment management in high-volume HIV clinics in Kenya. The cRCT will be conducted at up to 24 HIV care and treatment facilities located in Kisumu, Homabay, Migori county in Western Kenya, in which approximately 6000 HIV positive adolescents and young adults ages 10-24 years enrolled in HIV care, 900 caregivers of ALHIV, and 200 HCW will be recruited in this study. Clinics randomized to the DiSC intervention arm will use a data-driven system to assign ALHIV to different levels of care depending on their current and anticipated health care needs. The intervention will be delivered at the individual level by HCW providing routine care during routine HIV clinic visits. Clinics randomized to the control arm will continue with standard of care approaches for adolescent clinic visits (usually 1-3 monthly visits), regardless of health care needs and additional support as needed. As secondary objectives, this study also aims to evaluate the effectiveness of the DiSC intervention on ALHIV cascade outcomes (adherence, viral non-suppression) and receiving differentiated HIV care based on health status evaluation.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1911
Est. completion date November 30, 2023
Est. primary completion date September 19, 2023
Accepts healthy volunteers No
Gender All
Age group 10 Years to 24 Years
Eligibility Inclusion Criteria: - HIV-positive - Enrolled in HIV care - Provision of informed consent - Willing and able to give informed consent Exclusion Criteria: - Not able or willing to give informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Data-informed Stepped Care (DiSC)
The DiSC intervention is comprised of a data-driven system to assign adolescents to care based on their health needs and the different levels of care for each assignment group. The trajectory of services moves from a relative position of ALHIV autonomy to more intensive service provision. Intervention steps start with 1) multi-month refills or community treatment delivery (differentiated care); 2) a standard of care level for those with medical needs such as pregnancy or opportunistic infections or patient choice; 3) patient reminders/tracking and counseling and referral services for mental health needs; 4) case management of unsuppressed individuals, including enhanced counseling and case conference problem-solving

Locations

Country Name City State
Kenya Asumbi Health Centre Homa Bay
Kenya Homa Hills Health Centre Homa Bay
Kenya Kendu Adventist Hospital Homa Bay
Kenya Marindi Sub County Referral Hospital Homa Bay
Kenya Mbita District Hospital Homa Bay
Kenya Rachuonyo District Hospital Homa Bay
Kenya Rangwe Sub-District Hospital Homa Bay
Kenya Shirikisho Health Centre Homa Bay
Kenya Suba District Hospital Homa Bay
Kenya Nyabondo Mission Hospital Kisumu
Kenya Nyahera Sub County Hospital Kisumu
Kenya Nyang'oma Health Centre Kisumu
Kenya Rabour Health Centre Kisumu
Kenya St. Elizabeth Chiga Kisumu
Kenya Awendo Sub County Hospital Migori
Kenya Dede Health Centre Migori
Kenya Godkwer Migori
Kenya Macalder Mission Hospital Migori
Kenya Migori County Mission Hospital Migori
Kenya Nyamaraga Health Centre Migori
Kenya Rongo Sub County Hospital Migori
Kenya Sony Medical Centre Migori
Kenya St. Joseph's Mission Hospital Migori
Kenya Uriri Sub County Hospital Migori

Sponsors (2)

Lead Sponsor Collaborator
University of Washington Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of retention in care We will evaluate retention using a definition of missed visit. calculate the proportion of scheduled visits that are missed. Missed visits will be defined as a participant not seen within 30 days after each scheduled visit. Each scheduled visit will be classified as missed versus not missed. We will also analyze retention using loss to follow-up which will be defined as a participant not seen within 30 days of a scheduled visit and not return to care within the 12-month study period. 12 months
Secondary Proportion of viral load results showing viral non-suppression We will calculate the overall proportion of viral load test results that show non-suppression. Viral non-suppression will be defined as having HIV RNA viral loads (VL) >1,000 copies per milliliter. Each VL test result will be classified as VL suppressed vs. unsuppressed. 12 months
Secondary Rate of adherence Adherence will be defined as the number of pills dispensed divided by the number of days between visits. A percentage greater than 80% will be classified as good adherence. The level of adherence during the past inter-visit interval will be assessed at each visit. 12 months
Secondary Proportion of adolescents enrolled in differentiated care services The proportion of adolescents enrolled in differentiated care will be computed as participants who (1) have multi-month prescription refill intervals =3 months; and/or (2) are assigned to fast-track status. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2